Valuation: ATTANA AB

Market Cap 7.74M 814K 707K 662K 605K 1.14M 77.58M 1.16M 3.04M 38.76M 3.06M 2.99M 129M P/E 2024
-0.31x
P/E 2025 -1.11x
Enterprise Value 7.6M 799K 693K 649K 594K 1.12M 76.12M 1.14M 2.98M 38.03M 3M 2.93M 127M EV / Sales 2024
0.57x
EV / Sales 2025 5x
Free-Float
1.63%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 2025-03-31
Chief Executive Officer 56 2002-08-31
Director of Finance/CFO - -
Director TitleAgeSince
Director/Board Member 56 2012-08-05
Chairman 63 2015-09-30
Director/Board Member 62 2017-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 814K
+0.96%+3.27%-40.01%-42.75% 609M
-12.64%+16.48%+103.27% - 396M
-1.34%+26.72%-34.35%+10.51% 125M
-1.55%-4.15%+1.20%+61.78% 100M
Average -2.89%-0.86%+7.52%+9.85% 307.69M
Weighted average by Cap. -3.79%-3.02%+10.03%-22.23%

Financials

2024 2025
Net sales 6.61M 696K 604K 565K 517K 976K 66.27M 989K 2.6M 33.11M 2.61M 2.56M 110M 4.01M 422K 366K 343K 313K 592K 40.16M 599K 1.57M 20.07M 1.58M 1.55M 66.79M
Net income -12.78M -1.34M -1.17M -1.09M -999K -1.89M -128M -1.91M -5.01M -63.97M -5.05M -4.94M -213M -10.5M -1.1M -959K -898K -821K -1.55M -105M -1.57M -4.12M -52.58M -4.15M -4.06M -175M
Net Debt 1.17M 123K 107K 100K 91.56K 173K 11.73M 175K 460K 5.86M 462K 452K 19.51M -145K -15.3K -13.28K -12.43K -11.37K -21.47K -1.46M -21.75K -57.08K -728K -57.44K -56.19K -2.42M
Logo ATTANA AB
Attana AB is a Sweden-based biotechnology company specializing in in vitro characterization of molecular interactions mimicking in vivo conditions. The Company develops proprietary label-free biosensors, based on the Quartz Crystal Microbalance (QCM) technology, for biochemical, crude, sera and cell-based assays. Its products and research services are used by pharmaceutical and biotechnology companies to quality control the production line of a biological pharmaceutical or gain insight into advanced dynamic features of target molecules, as well as by academic institutions within the life sciences. Attana’s biosensors are used to determine specificity, kinetics and affinity, among other binding characteristics of biomolecules and macrostructures of varying species such as cells, antibodies, proteins, viruses and bacteria.
Employees
-